These results established the critical roles of hippocampal LIMK1/cofilin in early synaptic and memory deficits in APP/PS1 mice and suggested that LIMK1/cofilin signaling pathway may serve as potential therapeutic target to treat AD. This evidence concerns the gene LIMK1 and Alzheimer disease.